Cabenuva
Real-World Data Show Continued Virologic Suppression With Cabenuva
At CROI 2025, new research has shown high rates of continued virologic suppression with cabotegravir-rilpivirine ...
MARCH 25, 2025
Long-Acting Injectable Cabenuva Shows Strong Results in Adolescents
Data from the IMPAACT 2017/MOCHA study support the use of long-acting Cabenuva among virologically suppressed ...
JULY 25, 2024
FDA Grants New Indication for Cabenuva for Every-8–Week Dosing
The FDA extended the time between shots of Cabenuva to every two months to treat HIV-1 infection in virologically ...
FEBRUARY 1, 2022
Load more